BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hou YY, Zhou Y, Lu SH, Qi WD, Xu C, Hou J, Tan YS. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor. World J Gastroenterol 2009; 15(15): 1910-1913 [PMID: 19370794 DOI: 10.3748/wjg.15.1910]
URL: https://www.wjgnet.com/1007-9327/full/v15/i15/1910.htm
Number Citing Articles
1
Yoshiya Fujimoto, Takashi Akiyoshi, Tsuyoshi Konishi, Satoshi Nagayama, Yosuke Fukunaga, Masashi Ueno. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectumInternational Journal of Colorectal Disease 2014; 29(1) doi: 10.1007/s00384-013-1769-7
2
Ryo Takahashi, Satoshi Nagayama, Yukiko Mori, Hiroyoshi Isoda, Akihiko Yoshizawa, Toshiaki Manabe, Yoshiharu Sakai. A large cystic gastrointestinal stromal tumor of the rectum in the retrorectal spaceInternational Journal of Clinical Oncology 2010; 15(6) doi: 10.1007/s10147-010-0084-3
3
Burton L. Eisenberg, Jonathan C. Trent. Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumorsInternational Journal of Cancer 2011; 129(11) doi: 10.1002/ijc.26234
4
David Reynoso, Jonathan C Trent. Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developmentsCurrent Opinion in Oncology 2010; 22(4) doi: 10.1097/CCO.0b013e32833aaaad
5
Carla Rameri Alexandre Silva de Azevedo, Tadeu Ferreira Paiva, Benedito Mauro Rossi, Gustavo Cardoso Guimarães, Maria Dirlei Ferreira de Souza Begnami, Thiago Bueno Oliveira, Milton José Barros e Silva, Marcello Ferretti Fanelli, Celso Abdon Lopes de Mello. Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GISTInternational Journal of Clinical Oncology 2011; 16(3) doi: 10.1007/s10147-010-0133-y
6
H. Rejab, W. Ben Kridis, H. Ben Ameur, J. Feki, M. Frikha, M. Issam Beyrouti. Tumeur stromale rectale : à propos d’une observationPathologie Biologie 2013; 61(3) doi: 10.1016/j.patbio.2013.03.006
7
Mariem Ben Rekaya, Feryel Ksontini, Linda Bel Haj Kacem, Farah Sassi, Emna Harigua‐Souiai, Ryma Boujneh, Ahmed H'mayada, Yosra Zaimi, Mouna Ayadi, Mediha Trabelsi, Ridha Mrad, Soumaya Rammeh. Pathologic complete response to neoadjuvant imatinib of a gastric stromal tumor with concomitant mutations in KIT: A case report and literature reviewClinical Case Reports 2023; 11(6) doi: 10.1002/ccr3.7463
8
Manabu Kaneko, Shigenobu Emoto, Koji Murono, Hirofumi Sonoda, Masaya Hiyoshi, Kazuhito Sasaki, Yasutaka Shuno, Takeshi Nishikawa, Toshiaki Tanaka, Keisuke Hata, Kazushige Kawai, Hiroaki Nozawa. Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumorsSurgery Today 2019; 49(6) doi: 10.1007/s00595-018-1737-5
9
Jenia Jenab-Wolcott, Bruce Giantonio. Molecular Pathology of Neoplastic Gastrointestinal DiseasesMolecular Pathology Library 2013; 7 doi: 10.1007/978-1-4614-6015-2_9
10
Nalini Raju, Reetesh Pai, Mark Lane Welton. Colorectal Surgery2013;  doi: 10.1016/B978-1-4377-1724-2.00020-9
11
Paulo Rocha França Neto, Leandro Alves Gomes Ramos, Luciana Costa Silva, Cristiane Koizimi M Fernandes, Antônio Lacerda-Filho. Uso neoadjuvante do mesilato de imatinibe no tratamento de GIST retal volumoso: relato de casoRevista Brasileira de Coloproctologia 2011; 31(1) doi: 10.1590/S0101-98802011000100014
12
Tingting Wu, Xiaobin Cheng, Wenbin Chen. Complete response of advanced rectal gastrointestinal stromal tumors after imatinib treatment: A case report and literature reviewMedicine 2022; 101(32) doi: 10.1097/MD.0000000000029411